Research
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone
Irfan A. Dhalla, Muhammad M. Mamdani, Marco L.A. Sivilotti, Alex Kopp, Omar Qureshi and David N. Juurlink
CMAJ December 08, 2009 181 (12) 891-896; DOI: https://doi.org/10.1503/cmaj.090784
Irfan A. Dhalla
Muhammad M. Mamdani
Marco L.A. Sivilotti
Alex Kopp
Omar Qureshi
In this issue
Article tools
Respond to this article
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone
Irfan A. Dhalla, Muhammad M. Mamdani, Marco L.A. Sivilotti, Alex Kopp, Omar Qureshi, David N. Juurlink
CMAJ Dec 2009, 181 (12) 891-896; DOI: 10.1503/cmaj.090784
Jump to section
Related Articles
Cited By...
- Academic detailing to improve appropriate opioid prescribing: a mixed-methods process evaluation
- Prescription of oxycodone versus codeine after childbirth and risk of persistent opioid use: a population-based cohort study
- Impact of vitamin C on the reduction of opioid consumption after an emergency department visit for acute musculoskeletal pain: a double-blind randomised control trial protocol
- Systematic assessment of opioid advertisements in general medical journals
- Cohort profile: development and characteristics of a retrospective cohort of individuals dispensed prescription opioids for non-cancer pain in British Columbia, Canada
- Optimizing opioid prescriptions after laparoscopic appendectomy and cholecystectomy
- Impact of an emergency department opioid prescribing guideline on emergency physician behaviour and incidence of overdose in the Saskatoon Health Region: a retrospective pre-post implementation analysis
- Influence of opioid prescribing standards on health outcomes among patients with long-term opioid use: a longitudinal cohort study
- Patterns of opioid use (codeine, morphine or meperidine) in the Canadian population over time: analysis of the Longitudinal National Population Health Survey 1994-2011
- Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal
- Exponential growth of the USA overdose epidemic
- Relation between opioid-related harms and socioeconomic inequalities in Ontario: a population-based descriptive study
- Quantity of opioids consumed following an emergency department visit for acute pain: a Canadian prospective cohort study
- Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
- Rebuttal: Will the new opioid guidelines harm more people than they help?: No
- Les nouvelles recommandations sur les opioides nuiront-elles plus quelles aideront les gens?: Non
- Refutation : Les nouvelles recommandations sur les opioides nuiront-elles plus quelles aideront les gens?: Non
- Will the new opioid guidelines harm more people than they help?: No
- Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
- Availability of naloxone in Canadian pharmacies:a population-based survey
- Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
- Prise en charge des troubles de consommation dopioides en premiere ligne: Abstinence, methadone ou buprenorphine-naloxone?
- Effective Canadian policy to reduce harms from prescription opioids: learning from past failures
- National opioid crisis
- Trends and sex differences in prescription opioid deaths in British Columbia, Canada
- Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches
- Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths
- Tamper-resistant drugs cannot solve the opioid crisis
- Can naloxone prescription and overdose training for opioid users work in family practice?: Perspectives of family physicians
- Retrospective analysis of trends in dispensing long-acting non-tamper-resistant oxycodone near the Canada-United States border
- Neonatal opioid withdrawal and antenatal opioid prescribing
- Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: Evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program
- The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia
- Incidence of narcotic abuse during pregnancy in northwestern Ontario: Three-year prospective cohort study
- Trends in high-dose opioid prescribing in Canada
- Questionable content of an industry-supported medical school lecture series: a case study
- Patient therapeutic education: Placing the patient at the centre of the WHO analgesic ladder
- Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis
- Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study
- A Call For Evidence-Based Medical Treatment Of Opioid Dependence In The United States And Canada
- The right drug for the right patient: Caring for our patients while minimizing prescription drug misuse
- Effect of a course-based intervention and effect of medical regulation on physicians' opioid prescribing
- Opioids for chronic non-cancer pain
- Hope in Fort Hope: First Nations community is winning the battle against prescription drug abuse
- Dependance aux opioides
- Opioid dependence
- Don't tamper with oxycodone
- Opioids for osteoarthritis pain: benefits and risks
- Pratiques optimales de prescription: Que peuvent faire les medecins?
- Achieving optimal prescribing: What can physicians do?
- Prescription opioid use and misuse: Piloting an educational strategy for rural primary care physicians
- Controler la douleur et reduire l'usage abusif d'opioides: Questions d'ethique
- Controlling pain and reducing misuse of opioids: Ethical considerations
- Lessons from the past
- Opioids and chronic pain
- Opioids versus nonsteroidal anti-inflammatory drugs in noncancer pain
- Lignes directrices canadiennes sur l'utilisation securitaire et efficace des opioides pour la douleur chronique non cancereuse: Resume clinique pour les medecins de famille. Partie 1: population en general
- Pharmacists' experiences with dispensing opioids: Provincial survey
- Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians. Part 1: general population
- Usage abusif des opioides d'ordonnance: Quel est le vrai probleme et comment le reglons-nous?
- Lignes directrices canadiennes sur l'utilisation securitaire et efficace des opioides pour la douleur chronique non cancereuse: Resume clinique pour les medecins de famille. Partie 2: populations particulieres
- Prescription opioid abuse: What is the real problem and how do we fix it?
- Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians. Part 2: special populations
- Facing up to the prescription opioid crisis
- Increasing deaths involving oxycodone, Victoria, Australia, 2000-09
- Response
- We can't feel their pain, but we can understand their fears.
- Treating patients versus numbers
- Opioids, pain, and personality: The story of a substitute physician
- Survey of Ontario primary care physicians' experiences with opioid prescribing
- Chronic noncancer pain: Characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic
- Miconazole Oral Gel Increases Exposure to Oral Oxycodone by Inhibition of CYP2D6 and CYP3A4
- Opioides, douleur et personnalite: Recit d'un medecin remplacant
- Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario
- Has the time come to phase out codeine?
- High cost, dubious benefit
- Where are the drugs from?